Rolled oral thin films having a high level of active-ingredient loading
US-2024156727-A1 · May 16, 2024 · US
US9724309B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9724309-B2 |
| Application number | US-201113073022-A |
| Country | US |
| Kind code | B2 |
| Filing date | Mar 28, 2011 |
| Priority date | Mar 30, 2010 |
| Publication date | Aug 8, 2017 |
| Grant date | Aug 8, 2017 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention provides a film-form preparation having a rapid dissolution profile in the mouth and sufficient film strength, and also having excellent appearance and feel. More specifically, the present invention provides a film-form preparation including: a water-soluble and a polar organic solvent-soluble edible polymer; and polar organic solvent-insoluble drug particles.
Opening claim text (preview).
The invention claimed is: 1. A film-form preparation comprising: a water-soluble and polar organic solvent-soluble edible polymer; and polar organic solvent-insoluble drug particles, wherein said polar organic solvent-insoluble drug particles are contained in a particulate state within the film-form preparation, wherein a particle size of the drug particles is 0.1 to 60 μm, and wherein the content of the drug particles is 0.1 to 60 wt % of the total content of solids contained in the film-form preparation. 2. The film-form preparation according to claim 1 , wherein the edible polymer is a solid at normal temperatures. 3. The film-form preparation according to claim 1 , wherein the edible polymer is polyvinyl pyrrolidone and/or hydroxypropyl cellulose. 4. The film-form preparation according to claim 3 , wherein a molecular weight of the polyvinyl pyrrolidone ranges from 2,500 to 3,000,000. 5. The film-form preparation according to claim 3 , wherein a molecular weight of the hydroxypropyl cellulose ranges from 10,000 to 1,150,000. 6. The film-form preparation according to claim 3 , wherein the hydroxypropyl cellulose has a hydroxypropoxy group-substitution degree of 50 to 100%. 7. The film-form preparation according to claim 1 , wherein a solubility parameter of the polar organic solvent is not less than 9.7. 8. A method for producing a film-form preparation including a water-soluble and polar organic solvent-soluble edible polymer and polar organic solvent-insoluble drug particles, and the method comprising: preparing a liquid dispersion of a drug containing the edible polymer, the drug particles, and a polar organic solvent; forming the liquid dispersion of the drug into a thin layer; and drying the thin layer, wherein the particle size of the drug particles is 0.1 to 60 μm.
Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers {, poly(meth)acrylates, or polyvinyl pyrrolidone} · CPC title
Containing particulates characterized by their shape and/or structure (see also A61K8/04, A61K8/11, and A61K8/14, further aspects are classified in A61K2800/40 and subcodes) · CPC title
Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals · CPC title
Drug-containing films, membranes or sheets (A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence) · CPC title
Bronchodilators · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.